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Abstract  Introduction: In Africa 
alone, between 1000 – 4000 chil-
dren are blinded annually by  
conjunctivitis. In view of the 
changing aetiological agents 
documented in other parts of the 
world and evolving resistance of 
infective agents to  therapeutic 
agents, the present study was  
designed to define the bacterial 
agents, their antibiotic sensitivity 
pattern seen in AKTH, Kano,  
Nigeria. 
Patients and methods: This was a 
cross sectional prospective study 
done over a period of 3 months. 
Consecutive neonates who satis-
fied the inclusion criteria were 
recruited  until the sample size of 
175 was obtained. samples were 
transported to the laboratory 
within one hour. Gram staining 
and antibiotic sensitivity  were 
determined using standard  
technique.      
Results: The mean age at presenta-
tion was  5.7 ± 4.6days.  Results of 
the eye swabs showed that 97 
(55.4%) were bacteriologically 
positive while 78 (44.6%) yielded 
no growth. Staphylococcus aureus 
was the most frequently isolated 
organism and was most sensitive 
to ceftriaxone, (73.1%). Es-
cherichia coli was most sensitive 
to gentamicin (78.3%). Pseudomo-
nas aeruginosa nd Neisseria gon-
orrhea showed 100% sensitivity to 
ceftazidime and ceftriaxone re-
spectively. 
Conclusion: Staphylococcus 
aureus is the commonest bacterial 
agent responsible for neonatal con-
junctivitis. Staphylococcus aureus 
was most sensitive to ceftriaxone.  
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Introduction  
 
Neonatal conjunctivitis was originally described in 1750 
by Quellmaz.1 It is one of the most common infections 
occurring in the first month of life and remains an im-
portant cause of ocular morbidity of great health con-
cern2.  Faal3 noted that there were an estimated one and a 
half million blind children in the world in 1992 and 
every year about half a million more became blind. Neo-
natal conjunctivitis was responsible for blindness in the 
majority of these children  in countries of Asia and Af-
rica and.3 In Africa between 1000 – 4000 children suffer 
blindness annually as a consequence of conjunctivitis.4    
 
The major causes of neonatal conjunctivitis are, in de-
creasing order of frequency, chemical inflammation, 
bacterial infections and viral infections while bacteria 
are the major causes of infectious neonatal conjunctivi-
tis.5 The bacterial causes include sexually transmitted 
disease agents (Chlamydia trachomatis and Neisseria 
gonorrhoea), microorganisms from the skin 
(Staphylococcus aureus) and the mother’s gastrointesti-
nal tract (Pseudomonas spp and Escherichia coli) and 
Haemophilus influenzae among others. Neisseria gonor-
rhoea is an important aetiological agent of neonatal con-
junctivitis because of its potential damage to vision.6 It 
accounts for up  to 1.7% of all neonatal conjunctivitis 
recorded in the study from Benin, Nigeria.7 However the 
introduction of prophylactic measures has led to a de-
crease in the incidence of gonococcal and chlamydial 
neonatal conjunctivitis.8 Recent studies show that 
Staphylococcus aureus appears to be increasingly a 
common causative agent of neonatal conjunctivitis. I  
accounted for 60.5% of cases seen in Benin,7 and 42.4% 
of cases seen in Abakaliki6 both in Nigeria. 
 
In view of the changing aetiological agents documented 
in Nigeria and other parts of the world as well as  
evolving resistance of infective agents to routinely used 
therapeutic agents and the paucity of information on 
neonatal conjunctivitis in Nigeria, the present study was 
designed to identify the bacterial agents, their antibiotic 
sensitivity pattern and ocular clinical presentation f 





Subjects and methods 
 
This was a cross sectional, prospective study in which 
subjects were recruited over a period of three months 
(April to June 2010). Approval was obtained from the 
Ethics Committee of Aminu Kano Teaching Hospital 
and informed and written consent of the primary care 
givers of subjects were obtained. Aminu Kano Teaching 
Hospital (AKTH) is located in Kano metropolis. It is a 
tertiary centre with a bed capacity of 500. The catch-
ment areas of the hospital include Jigawa, Bauchi , 
Katsina and Yobe states. The paediatric department of 
the hospital consists of five units; the Special Care Baby 
Unit, the Emergency Paediatric Unit, Paeditric Medical 
Ward, Paediatric Outpatient Unit and Paediatric Spe-
cialty Clinic. The SCBU is located adjacent to labour 
room and it consists of the inborn unit for neonates d -
livered in the hospital and out born unit for neonates 
delivered outside the hospital who require  
hospitalization. 
 
Consecutive neonates who satisfied the inclusion criteria 
were recruited from the Special Care Baby Unit, the post 
natal ward and paediatric outpatient unit of the hospital 
until the desired sample size of 175 was obtained. The 
sample size was determined based on the highest preva-
lence of positive bacterial isolates of 13.15% repoted 
from Ilorin.2 Inclusion criteria were: all babies within 
the age of 0 –28 days presenting at Special Care Baby 
Unit, paediatric outpatient unit, the postnatal ward nd 
labour ward with discharge from one or both eyes. 
Relevant information was collected using a pre-tested 
questionnaire administered to caregivers in interview 
sessions.  Birth weight was recorded for all inborn ba-
bies and for those delivered in other hospitals where the 
information was available. For those without birth e-
cords the weight and age at presentation were deter-
mined.  
 
Physical examination was conducted on all study sub-
jects and the severity of the conjunctivitis was  scored  
in each case using the method described by Christian.9 
Scores were awarded as 1+, 2+ and 3+ for mild, moder-
ate and severe cases respectively. Conjunctival swabs 
were collected from the eyes of the subjcts  with the aid 
of sterile swab sticks and samples were then immersed 
in the broth in universal bottles and transported to the 
laboratory within 30 minutes to one hour. The broth 
consists of peptone, Beef extracts and sodium chloride 
which serve as nutrient for the pathologic organisms. 
 
Smears of the specimens were made on glass slides an  
fixed using heat and alcohol. Gram staining of the slides 
was carried out using standard techniques. The swabs 
were also inoculated on the chocolate agar plates and 
were incubated for 24-48 hours at 37oC. Aerobic isolates 
were identified by the standard methods of Cowan 
(1974).10 Anaerobes were not studied due to lack of fa-
cilities. Antibiotic sensitivity of the isolates was deter-
mined using standard disc diffusion technique.11 How-
ever antibiotic sensitivity for Chlamydia was not done 
due to lack of facilities. Diagnosis of chlamydial nfec-
tion was done through detection of Chlamydial antigens 
using a rapid immunochromatographic technique (ICT). 
After collection of specimens, patients were managed in 
accordance with standard departmental guidelines.  
 
The data generated were entered into a Microsoft Excel 
spreadsheet and analyzed using EPI INFO version 3.5.1
2002. Continuous variables were summarized using 
means, medians, and ranges as appropriate. Frequency 
tables were generated and cross–tabulations to observe 
the relationship between categorical variables were 
done. Proportions were compared using Chi-square test 
of significance. A probability (p–value) of less than 0.05 






A total of one hundred and seventy five (175) neonates 
that met the study criteria were studied. The age rnge of 
subjects at presentation was 1-24 days with the mean of 
5.7 ± 4.6 days. Ninety one (52.0%) neonates were mal s 
while eighty four (48%) were females with a male: f-
male ratio of 1.1:1. A total of 1602 neonates were se n 
in AKTH during the study period thus giving an inci-
dence of neonatal conjunctivitis of 60.5 per 1000 live 
births in this study. 
 
Table 1: Distribution of age at onset of conjunctivitis   
# The unequal age intervals were used to reflect the incubation 
periods of common aetiologic agents of neonatal  
conjunctivitis. 
 
Table 2: shows the bacterial agents isolated in neonat s 
with conjunctivitis. Results of the eye swabs showed 
that 97 (55.4%) were bacteriologically positive while 78 
(44.6%) yielded no growth. Six bacterial genera were 
isolated, of which Staphylococcus aureus was the most 
frequently isolated organism.  Klebsiella species and 
Neisseria gonorrhoea were the least isolated organisms 
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Male % Female % 
0 – 2   
3 – 5 






















Total 175 91 52 84 48 
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Table 2:   Bacterial isolates and Chlamydia antigen positivity 
in neonates with conjunctivitis. 
Antibiotic sensitivity of bacterial agents isolated 
 
The sensitivity of 92 bacterial agents isolated wastested. 
Staphylococcus aureus was most sensitive to  






















Total 175 100 
ceftriaxone, recorded in 38 cases (73.1%), followed by  
gentamicin and ceftazidime in 32 cases (61.5%) and 30 
(57.7%) cases each.  Escherichia coli was most sensitive 
to gentamicin observed in 18 (78.3%) cases, followed by 
ceftazidime, ceftriaxone and ofloxacin with 17 (73.9%), 
15 (65.1%) and 12 (52.2%) cases respectively. 
 
Sensitivity of Neisseria gonorrhoea to ceftriaxone was 
demonstrated in all the 3 (100%) cases but it was  
resistant to ceftazidime, erythromycin, ofloxacin, cipro-
floxacin, augmentin and amoxicillin. 
Table 3: Antibiotic sensitivity pattern of bacterial isolates seen in neonatal conjunctivitis 
  Antibiotics 
Organisms No of 
isolates 
AMX  AUG 
  

























































































Total 97 4(4.3) 14(15.2) 22(23.9) 61(66.3) 23(25.0) 10(10.9) 56(60.9) 60(65.2) 29(31.5) 15(16.3) 
AMX=Amoxicillin AUG=Augmentin ERY=Erythromycin GEN=Gentamicin CPC=Chloramphenicol CTZ=Ceftazidime OFL = Ofloxacin NT=  
Not tested  






The mean age at presentation of 5.7 days of the neonat s 
with neonatal conjunctivitis in this study is similar to 4.6 
days observed in Abakaliki, Nigeria, by Ibekwe.6 It is 
however lower than 12.9 days documented by Ugbode13  
from Zaria  (Nigeria) . On the other hand, it is slightly 
higher than five days obtained by Abdulkadir14 n a later 
Zaria study in 2008. The incubation period of the pr -
dominant aetiological agent in a locality may partly ex-
plain the difference in age at presentation.  
 
The male to female ratio in the current study of 1.1:1 is 
similar to the 1.2:1 ratio recorded by Ibekwe6 from 
Abakaliki but differs from that of Olatunji13 and Mohile 
et al 15 who documented a male: female ratio of 1:1.5. It 
is however  lower than the ratio of 1.5:1  recorded by 
Ugbode12 from Zaria, Nigeria.  Males have approxi-
mately twofold higher incidence of sepsis than females 
suggesting the possibility of a sex-linked factor in host 
susceptibility to infection.16 Staphylococcus aureus was 
the most commonly isolated bacterium in this study. 
This was in keeping with the findings of Ugbode12 in 
Zaria as well as Iyamu and Enabule7 in Benin City. 
However, it differed from that of Ernest2 who recorded 
Chlamydia trachomatis as the predominant organism of 
neonatal conjunctivitis in Ilorin. 
 
The predominance of Staphylococcus aureus in this 
study may suggest that most of the cases of neonatal 
conjunctivitis were postnatally acquired rather than dur-
ing passage through the birth canal. Ibrahim et al17 in 
Kano also reported S. aureus as the dominant isolate 
(42.1%) among neonates from a study of bacteramia 
among febrile children aged 0-14 years conducted over a 
period of one year. Virulence factors possessed by  
S. aureus make it to be the commonest agent of infec-
tion in children including neonates.18 
 
The positive isolate rate of (13.1%) for Escherichia coli 
in neonatal conjunctivitis found in this study is compara-
ble to the report by Kolade19 and Iyamu et al7 from Ilorin 
and Benin who found positive isolate rate of 10.08% and 
12.5% for E. coli respectively. It is however higher than 
6.1% reported by Ibekwe et al.6 A low rate of Neisseria 
gonorrhoea (1.7%) neonatal conjunctivitis was found in 
this study. This is similar to 1.6% positive isolate rate 
recorded by Iyamu7 from Benin but higher than 0.84% 
rate reported by Kolade19 from Ilorin It may be sug-
gested that the low rate N. gonorrhoea obtained in this 
study may be due to availability of health facilities and 
improved health habits. It may also be due to fastidious 
nature of N. gonorrhea 
 
Staphylococcus aureus howed a good sensitivity to 
ceftriaxone (73.1%) and ceftazidime (57.7%). This find-
ing is in keeping with that by Schobers.21 The sensitivity 
rate of Staphylococcus aureus to gentamicin in this 
study (61.5%) is lower than the findings of Kolade20 and 
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Onile et al22 who reported much higher sensitivities of 
89.29% and 100% respectively. It is however higher 
than 42.8% reported by Ibekwe6 from Abakaliki. The 
relatively high sensitivity of Staphylococcus aureus to 
ceftriaxone, ceftazidime and gentamicin could be ex-
plained by low potential for abuse as these drugs are 
present only in injectable and topical forms.  
 
Escherichia coli showed a high sensitivity of 78.3% to 
gentamicin which is however, lower than the 100% re-
ported by Ibekwe et al.6  The sensitivity of Escherichia 
coli to ceftazidime(73.9%) and ceftriaxone(65.2%) is 
similar to the report of Kolade.19   Neisseria gonorrhoea 
was highly sensitive to ceftriaxone (100%). The higher 
sensitivity of  E. coli to these antibiotics may be due to 
the fact that they are present only in injectable forms, 
hence not commonly abused, thus less likelyhood of 
resistance. 
Conclusion 
Staphylococcus aureus and Escherichia coli are the 
commonest bacterial agents responsible for neonatal 
conjunctivitis in Aminu Kano Teaching Hospital. We 
therefore, recommend the use of Ceftriaxone and topical 
Gentamycin to treat neonatal conjunctivitis in 
Kano.Periodic survey should also be carried out to iden-
tify any change in the aetiological agents of neonatal 
conjunctivitis so as to guide modification in the tr at-
ment plan of the disease. 
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